David Mountcastle sold $210k of PRVA
EVP & Chief Financial Officer at Privia Health Group, Inc.. 8,385 shares at an average of $25.03, traded May 1, 2026, filed May 5, 2026.
Score components
- +22RoleCFO
- +12Trade size$210k at market
- 0Share of holdings soldSold 3.8% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001858396-26-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 1, 2026 | MOption exercise Common Stock, par value $0.01 per share10b5-1 | +7,179 | $2.00 | $14k | 222,026 | May 5, 2026 |
| May 1, 2026 | SOpen-market sale Common Stock, par value $0.01 per share10b5-1 | -7,179 | $25.03 | $180k | 214,847 | May 5, 2026 |
| May 4, 2026 | MOption exercise Common Stock, par value $0.01 per share10b5-1 | +1,206 | $2.00 | $2,412 | 216,053 | May 5, 2026 |
| May 4, 2026 | SOpen-market sale Common Stock, par value $0.01 per share10b5-1 | -1,206 | $25.00 | $30k | 214,847 | May 5, 2026 |
| May 1, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -1,297 | $0.00 | $0 | 1,538 | May 5, 2026 |
| May 1, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -541 | $0.00 | $0 | 1,053 | May 5, 2026 |
| May 1, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -3,010 | $0.00 | $0 | 9,489 | May 5, 2026 |
| May 1, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -2,331 | $0.00 | $0 | 6,322 | May 5, 2026 |
| May 4, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -202 | $0.00 | $0 | 1,336 | May 5, 2026 |
| May 4, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -52 | $0.00 | $0 | 1,001 | May 5, 2026 |
| May 4, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -592 | $0.00 | $0 | 8,897 | May 5, 2026 |
| May 4, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -360 | $0.00 | $0 | 5,962 | May 5, 2026 |
Related signals
Other insiders at Privia Health Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $589k 21,275 shares | -11% | |
| 10Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $17k 600 shares | -0% | |
| 33Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $3.1M 112,759 shares | -83% | |
| 36Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $680k 24,734 shares | -12% | |
| 33Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $3.6M 135,498 shares | -105% | |
| 33Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $3.8M 151,322 shares | -92% | |
| 12Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $433k 17,196 shares | -8% | |
| 50Moderate | Privia Health Group, Inc. | Parth Mehrotra Chief Executive Officer | $2.7M 121,086 shares | -22% | |
| 45Moderate | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $77k 3,385 shares | -2% | |
| 17Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $453k 18,113 shares | -21% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.